KLOW – TB-500 10mg / BPC-157 10mg / KPV 10mg / GHK-Cu 50mg

For research use only — not for human or veterinary use.

Analytical Verification (COA)

Each batch of Klow 80 mg supplied by Grail Formula undergoes independent third-party laboratory verification to confirm compound identity, assay content, purity and microbiological safety. Analytical testing for this batch was performed by Liquilabs s.r.o. (Czechia) using validated chromatographic and spectrometric techniques. Batch: GF-KLOW-B242 Key analytical results include:

• GHK-Cu Assay: 62.1 mg
• TB-500 Assay: 14.96 mg
• BPC-157 Assay: 13.63 mg
• KPV Assay: 10.09 mg
• GHK-Cu Purity: greater than 99.8 percent
• TB-500 Purity: 99.8 percent
• BPC-157 Purity: 99.4 percent
• KPV Purity: greater than 99.8 percent
• GHK-Cu Identification – RT: 0.992
• TB-500 Identification – RT: 0.983
• BPC-157 Identification – RT: 0.981
• KPV Identification – RT: 0.993
• Molecular Ion Mass Identification (GHK-Cu): confirmed
• Molecular Ion Mass Identification (TB-500): confirmed
• Molecular Ion Mass Identification (BPC-157): confirmed
• Molecular Ion Mass Identification (KPV): confirmed
• Bacterial Endotoxins: below 0.001 EU per mg
• Total Aerobic Microbial Count: not detected
• Total Yeast and Mold Count: not detected

Independent heavy metal screening confirmed no detectable levels of arsenic, cadmium, cobalt, lead, nickel, mercury or vanadium. These analytical procedures ensure traceability, purity verification and laboratory-grade compound consistency. :contentReference[oaicite:1]{index=1}

Product Overview

Klow 80 mg is a multi-peptide research blend studied in controlled laboratory environments focused on peptide-mediated signalling pathways and molecular regulatory systems. The formulation combines GHK-Cu, TB-500, BPC-157 and KPV in a high-purity lyophilized preparation designed for controlled in vitro experimentation. This preparation contains a total peptide content exceeding the labelled amount based on independent analytical verification. The lyophilization process preserves peptide stability and allows precise laboratory reconstitution. Due to its defined multi-peptide composition and stable analytical profile, Klow 80 mg is frequently referenced in experimental peptide research models.

Compound Overview

Klow 80 mg combines multiple synthetic peptides studied for their interaction with signalling pathways and regulatory systems. Within experimental models, the blend is commonly investigated for peptide-mediated signalling dynamics and molecular interaction mechanisms. Because of its defined molecular profile, the compound blend is frequently used in laboratory studies examining peptide signalling and regulatory processes.

Historical Background and Scientific Context

Scientific interest in peptide combinations has expanded significantly with advances in molecular biology and biochemical research. Multi-peptide formulations such as Klow 80 mg have been developed to explore signalling pathways and peptide interactions in controlled laboratory environments. This has enabled deeper investigation into molecular mechanisms and peptide-mediated biological processes.

Mechanistic Focus in Research

Within experimental laboratory settings, Klow 80 mg is commonly studied in relation to peptide-mediated signalling pathways. Research investigations commonly explore the blend in experimental models examining:

• Peptide signalling pathways
• Regulatory network interactions
• Peptide interaction dynamics
• Intracellular signalling mechanisms
• Comparative peptide research
• Molecular signalling pathway analysis
• Receptor interaction modelling

These experimental models allow scientists to investigate molecular mechanisms involved in peptide-mediated signalling processes.

Research Applications

In controlled research environments, Klow 80 mg may be utilised in experimental models designed to explore peptide signalling systems and molecular interactions. Examples of research applications include:

• Peptide signalling pathway investigation
• Receptor interaction research
• Intracellular signalling modelling
• Comparative peptide studies
• Molecular pathway analysis
• Controlled in vitro research
• Laboratory signalling studies

Grail Formula Quality

Every Grail Formula research compound is produced under strict quality control procedures designed to support reliable laboratory experimentation. Each batch undergoes independent analytical testing to verify:

• Compound identity
• Assay accuracy
• Purity confirmation
• Mass spectrometry identity verification
• Microbial safety
• Endotoxin levels
• Heavy metal screening
• Full batch traceability

All testing is performed by independent laboratories to ensure transparent verification and reproducible research material.

Research Use Limitation

• Used solely for in vitro experiments
• Not permitted for clinical trials involving humans
• Not permitted for human or veterinary administration
• Not permitted for investigational human use

• Independently analysed by Liquilabs s.r.o. Czechia
• Multi-peptide assay verification per compound
• GHK-Cu 62.1 mg, TB-500 14.96 mg, BPC-157 13.63 mg and KPV 10.09 mg confirmed
• Identity confirmed through MS Deconvolution
• Endotoxin level below 0.001 EU/mg
• No detectable heavy metals or microbial contamination
• For research use only – not for human or veterinary use

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.